Literature DB >> 11082508

Oligoclonal expansions in the CD8(+)CD28(-) T cells largely explain the shorter telomeres detected in this subset: analysis by flow FISH.

F M Batliwalla1, N Rufer, P M Lansdorp, P K Gregersen.   

Abstract

We have previously reported that CD8(+)CD28(-) T cells have relatively shorter telomeres compared with CD8(+)CD28(+) T cells. Oligoclonal expansion is a common feature of CD8(+) T cells in human peripheral blood, and these expansions predominantly occur in the CD57(+)/CD28(-) population. We studied the telomere length in subsets of CD8(+) T cells using quantitative fluorescence in situ hybridization and flow cytometry (flow FISH). Our results confirm that CD8(+)CD28(-) T cells have shorter telomeres as compared with their CD28(+) counterpart cells. In addition, the oligoclonally expanded cells within the CD8(+)CD28(-) T cell subset generally have even shorter telomeres than the CD28(-) subset as a whole. We conclude that the presence of clonal expansions in the CD8(+)CD28(-) T cell population largely explain the shorter telomeres in this subset. These clonally expanded CD8(+)CD28(-) T cells generally have characteristics of terminally differentiated effector cells. Nevertheless, there is considerable individual variation in the degree of telomere shortening in these cells, which may reflect host genetic factors as well as the type and timing of the antigenic exposure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082508     DOI: 10.1016/s0198-8859(00)00157-9

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  17 in total

Review 1.  Do functional subsets of leukocytes arise by divergent or linear differentiation?

Authors:  Alistair Noble; David M Kemeny
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

2.  Generation and growth of CD28nullCD8+ memory T cells mediated by IL-15 and its induced cytokines.

Authors:  Wai Kan Chiu; Monchou Fann; Nan-ping Weng
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

3.  CXCR3 and alphaEbeta7 integrin identify a subset of CD8+ mature thymocytes that share phenotypic and functional properties with CD8+ gut intraepithelial lymphocytes.

Authors:  F Annunziato; L Cosmi; F Liotta; E Lazzeri; P Romagnani; R Angeli; L Lasagni; R Manetti; F Marra; C Gerard; I Petrai; P Dello Sbarba; F Tonelli; E Maggi; S Romagnani
Journal:  Gut       Date:  2005-12-20       Impact factor: 23.059

4.  A ticket to the gut for thymic T cells.

Authors:  W Falk
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

5.  Assessment of telomere length, phenotype, and DNA content.

Authors:  Ingrid Schmid; Beth D Jamieson
Journal:  Curr Protoc Cytom       Date:  2004-09

Review 6.  T-cell biology in aging, with a focus on lung disease.

Authors:  Naeun Lee; Min Sun Shin; Insoo Kang
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-05       Impact factor: 6.053

7.  Age-related telomere length dynamics in peripheral blood mononuclear cells of healthy cynomolgus monkeys measured by Flow FISH.

Authors:  Won-Woo Lee; Ki-Hoan Nam; Keiji Terao; Yasuhiro Yoshikawa
Journal:  Immunology       Date:  2002-04       Impact factor: 7.397

8.  Increased activation and oligoclonality of peripheral CD8(+) T cells in the chronic human helminth infection alveolar echinococcosis.

Authors:  Burkhard J Manfras; Stefan Reuter; Thomas Wendland; Peter Kern
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

9.  CD28⁻ CD8⁺ T cells are significantly reduced and correlate with disease duration in juveniles with type 1 diabetes.

Authors:  Danielle N Yarde; Kristina Lorenzo-Arteaga; Kevin P Corley; Monina Cabrera; Nora E Sarvetnick
Journal:  Hum Immunol       Date:  2014-09-19       Impact factor: 2.850

10.  BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus-specific human CD8(+) T cells.

Authors:  J Merino; N Ramírez; C Moreno; E Toledo; M Fernández; A Sánchez-Ibarrola
Journal:  Clin Exp Immunol       Date:  2007-04-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.